136 related articles for article (PubMed ID: 29035657)
1. Evaluation of mortality rate and predictors of outcome in dogs receiving outpatient treatment for parvoviral enteritis.
Sarpong KJ; Lukowski JM; Knapp CG
J Am Vet Med Assoc; 2017 Nov; 251(9):1035-1041. PubMed ID: 29035657
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the use of antiemetic agents in dogs with parvoviral enteritis treated at a veterinary teaching hospital: 77 cases (1997-2000).
Mantione NL; Otto CM
J Am Vet Med Assoc; 2005 Dec; 227(11):1787-93. PubMed ID: 16342528
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an outpatient protocol in the treatment of canine parvoviral enteritis.
Venn EC; Preisner K; Boscan PL; Twedt DC; Sullivan LA
J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):52-65. PubMed ID: 27918639
[TBL] [Abstract][Full Text] [Related]
4. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial.
Martin V; Najbar W; Gueguen S; Grousson D; Eun HM; Lebreux B; Aubert A
Vet Microbiol; 2002 Oct; 89(2-3):115-27. PubMed ID: 12243889
[TBL] [Abstract][Full Text] [Related]
5. Effect of parvoviral enteritis on plasma citrulline concentration in dogs.
Dossin O; Rupassara SI; Weng HY; Williams DA; Garlick PJ; Schoeman JP
J Vet Intern Med; 2011; 25(2):215-21. PubMed ID: 21281355
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators at presentation for canine parvoviral enteritis: 322 cases (2001-2018).
Chalifoux NV; Parker SE; Cosford KL
J Vet Emerg Crit Care (San Antonio); 2021 May; 31(3):402-413. PubMed ID: 33792158
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Efficacy of Maropitant Versus Ondansetron in the Treatment of Dogs with Parvoviral Enteritis.
Sullivan LA; Lenberg JP; Boscan P; Hackett TB; Twedt DC
J Am Anim Hosp Assoc; 2018; 54(6):338-343. PubMed ID: 30272481
[TBL] [Abstract][Full Text] [Related]
8. Use of oseltamivir in the treatment of canine parvoviral enteritis.
Savigny MR; Macintire DK
J Vet Emerg Crit Care (San Antonio); 2010 Feb; 20(1):132-42. PubMed ID: 20230441
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serum acute-phase proteins in dogs with parvoviral enteritis.
Kocaturk M; Martinez S; Eralp O; Tvarijonaviciute A; Ceron J; Yilmaz Z
J Small Anim Pract; 2010 Sep; 51(9):478-83. PubMed ID: 20630018
[TBL] [Abstract][Full Text] [Related]
10. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis.
Otto CM; Drobatz KJ; Soter C
J Vet Intern Med; 1997; 11(2):65-70. PubMed ID: 9127292
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis.
Mischke R; Barth T; Wohlsein P; Rohn K; Nolte I
Res Vet Sci; 2001 Jun; 70(3):221-5. PubMed ID: 11676617
[TBL] [Abstract][Full Text] [Related]
12. Update on Canine Parvoviral Enteritis.
Mazzaferro EM
Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1307-1325. PubMed ID: 32891439
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of lipid profiles in dogs with parvoviral enteritis.
Yilmaz Z; Senturk S
J Small Anim Pract; 2007 Nov; 48(11):643-50. PubMed ID: 17617157
[TBL] [Abstract][Full Text] [Related]
14. Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis.
Mann FA; Boon GD; Wagner-Mann CC; Ruben DS; Harrington DP
J Am Vet Med Assoc; 1998 May; 212(9):1398-401. PubMed ID: 9589125
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991).
Houston DM; Ribble CS; Head LL
J Am Vet Med Assoc; 1996 Feb; 208(4):542-6. PubMed ID: 8603904
[TBL] [Abstract][Full Text] [Related]
16. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis.
Mohr AJ; Leisewitz AL; Jacobson LS; Steiner JM; Ruaux CG; Williams DA
J Vet Intern Med; 2003; 17(6):791-8. PubMed ID: 14658714
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection.
Iris Kalli ; Leontides LS; Mylonakis ME; Adamama-Moraitou K; Rallis T; Koutinas AF
Res Vet Sci; 2010 Oct; 89(2):174-8. PubMed ID: 20303134
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against canine parvoviral enteritis in healthy dogs.
Marsilio F
Vet Rec; 2015 Dec; 177(23):595-6. PubMed ID: 26667433
[No Abstract] [Full Text] [Related]
19. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial.
de Mari K; Maynard L; Eun HM; Lebreux B
Vet Rec; 2003 Jan; 152(4):105-8. PubMed ID: 12572939
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Salmonella in juvenile dogs affected with parvoviral enteritis.
Botha WJ; Schoeman JP; Marks SL; Whitehead Z; Annandale CH
J S Afr Vet Assoc; 2018 Dec; 89(0):e1-e6. PubMed ID: 30551702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
